Valens in the News

Boston, MA – Valens Research is excited to announce a new partnership with Cbonds, a financial market data vendor covering global bonds, equities and ETFs. Thanks to this collaboration, Cbonds users can now access Valens Research’s daily analytical reports directly on Cbonds platform, providing deeper insights to support smarter investment decisions.

Valens Research COO and Director of Research Rob Spivey, CFA returns to Money Life with Chuck Jaffe to discuss AI, the recent upturn in the corporate debt outlook, and Valens’ latest market calls powered by Uniform Accounting.

Valens Research COO and Director of Research Rob Spivey, CFA weighs in on plight of debt-laden “zombie” companies.

Valens Research’s Director of Research, Robert Spivey, CFA, was interviewed on the @stustreetofficial. Spivey shares key insights on career success, emphasizing the value of networking and seeking advice. Reflecting on his journey in buy-side finance, he highlights the experience of building his own company under the mentorship of his former boss. Spivey also emphasizes the importance of a strong, structured argument, influenced by his background in philosophy, for effective communication in the financial realm.

In the Market Call, Rob Spivey, Valens Research’s Director of Research, says he expects a “supply chain super cycle” to help sustain or even spur economic growth as consumer spending slows in the face of inflation. This should support the economy as it goes through a transition. However, he notes that those conditions should make stock investors particularly picky about what they are buying now.

Valens Research’s Chairman and CEO, Professor Joel Litman, was interviewed by Stansberry Research’s @Daniela Cambone. Prof. Litman talked about the recent sell-offs seen in the U.S. stock market, and how the demand-driven inflation is not great, but it’s not as deadly as inflation driven by currency devaluation.

I was on the Money Life with Chuck Jaffe show that came out today, talked about Valens’ investment research process, big macro things we think are interesting (capex supercycle and oil & gas capex), and some interesting names we like, and would avoid.

Valens Research’s Director of Research, Robert Spivey, was quoted on Bloomberg in an article explaining how longstanding accounting standards misclassify billions of dollars and how stock gains are not justified by earnings.

Valens Research’s Director of Research, Robert Spivey, was interviewed on the Money Life Show with Chuck Jaffe. In this interview, he talked about the Uniform Accounting method, survive-and-thrive stocks, and more in the Market Call.

Valens Research’s CEO and Chief Investment Strategist, Professor Joel Litman, published an article on Forbes regarding the latest predictions of Wall Street on Goldman’s Tech Index and Volatility.

Valens Research’s Director of Research, Robert Spivey, was interviewed on the Money Life Show with Chuck Jaffe. In this interview [34:35], he talks about survive-and-thrive stocks and more in the Market Call.

Valens Research’s Director of Research, Robert Spivey with DI Partner John Sviokla at Growth Innovators Speaker’s Series. Most breakthrough innovations take at least 5 years or more to come to scale. Most corporate business cases are three years or less. This punishes innovators massively. Combine this with the fact that the tenure in most corporations is less than 5 years—and you have a no-win situation for innovation. In this online event, Spivey and Sviokla discuss two ways to stop punishing the innovators: fancy and simple. The fancy way is to capitalize your R&D efforts according to an empirically derived amortization schedule specific to sector. The easy way is to use a 5-year NPV on innovation, like Amazon does. They also explain why, using insights from a 25,000-company global database on financial performance.

Valens Research’s Uniform Accounting data was used as source of a study conducted by Digital Intent. Based on the research conducted, there are eight principles to help companies become growth innovators and not only survive–but thrive–during a crisis.

Valens Research’s Director of Research, Robert Spivey, was interviewed on the Money Life Show with Chuck Jaffe. In this interview [38:07], he discussed how #UniformAccounting reveals the true economic profitability and valuations of companies.

President and CEO of Valens Research and Chief Investment Strategist of Altimetry Financial Research, Professor Joel Litman published an article on Forbes titled, “The Next Big Bath: Wall Street Is Blind To An Oncoming Earnings Disaster.” In this article, he discussed his insights on how the next “Big Bath” during this pandemic is happening, and why Wall Street analysts are directionally wrong in their earnings forecasts.

Robert Spivey of Valens Research discusses the process his firm uses to better compare a company’s financial reports, and identifies nine stocks that face potential dividend cuts.

Your home is your castle. A lot more will be spent on that castle in the coming years. COVID-19 is just an accelerator of that trend.

A very high dividend yield typically means investors are no longer confident a company can maintain its dividend payout.

Allocating investments based on the “100 minus your age” rule? You’re likely leaving money on the table. Rules of thumb like this leave most with significant portfolio underperformance.

The problem isn’t that metrics like EBITDA and adjusted EPS are adjusting too much, it’s that they aren’t consistent.